Literature DB >> 6164284

Propranolol: the preferred palliation for tetralogy of Fallot.

A Garson, P C Gillette, D G McNamara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6164284     DOI： 10.1016/0002-9149(81)90219-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

1.  Pathophysiologic consequences of cyanotic congenital heart disease.

Authors:  P S Rao
Journal:  Indian J Pediatr       Date:  1983 Sep-Oct       Impact factor: 1.967

2.  Factors affecting left ventricular function after correction of tetralogy of Fallot.

Authors:  M de Lorgeril; B Friedli; A Assimacopoulos
Journal:  Br Heart J       Date:  1984-11

3.  Stability of propranolol in extemporaneously compounded suspensions.

Authors:  Mary H H Ensom; Jennifer Kendrick; Susan Rudolph; Diane Decarie
Journal:  Can J Hosp Pharm       Date:  2013-03

4.  Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.

Authors:  Samar R El Khoudary; Anthony Fabio; Jessie W Yester; Matthew L Steinhauser; Adam B Christopher; Frank Gyngard; Phillip S Adams; Victor O Morell; Melita Viegas; Jose P Da Silva; Luciana F Da Silva; Mario Castro-Medina; Andrew McCormick; Miguel Reyes-Múgica; Michelle Barlas; Honghai Liu; Dawn Thomas; Niyatie Ammanamanchi; Rachel Sada; Megan Cuda; Elizabeth Hartigan; David K Groscost; Bernhard Kühn
Journal:  Int J Cardiol       Date:  2021-07-12       Impact factor: 4.164

Review 5.  Multi-detector computed tomography in the assessment of tetralogy of Fallot patients: is it a must?

Authors:  Mahmoud Shaaban; Sara Tantawy; Fatma Elkafrawy; Dina Haroun; Soha Romeih; Wesam Elmozy
Journal:  Egypt Heart J       Date:  2020-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.